U.S. Markets open in 2 hrs 48 mins

Tetraphase Pharmaceuticals, Inc. (TTPH)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.41+0.06 (+0.82%)
At close: 4:00PM EDT
People also watch
CEMPCMRXPTCTESPRZFGN
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue5,14511,6869,098
Cost of Revenue---
Gross Profit5,14511,6869,098
Operating Expenses
Research Development63,76473,76861,932
Selling General and Administrative19,21120,91612,932
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-77,830-82,998-65,766
Income from Continuing Operations
Total Other Income/Expenses Net3504041
Earnings Before Interest and Taxes-77,480-82,958-65,725
Interest Expense-2311,017
Income Before Tax-77,480-83,189-66,742
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-77,480-83,189-66,742
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-77,480-83,189-66,742
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-77,480-83,189-66,742